A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single dose 600 mg gabapentin will be given preoperatively in anal surgeries

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Perioperative Administration of Gabapentin for Reducing Inhalational Anesthetic Consumption

NCT05301205

Gabapentin

UNKNOWN EARLY_PHASE1

The Effect of Gabapentin on Spinal Anesthesia Duration

NCT05659810

Prolongation of Spinal Anesthesia

COMPLETED EARLY_PHASE1

Effect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia

NCT05150795

Post Operative Pain, Acute

RECRUITING EARLY_PHASE1

Effect of Perioperative Gabapentin on Postoperative Opioid Requirements

NCT05494385

Postoperative Pain

COMPLETED PHASE4

Effect of Gabapentin on Post-Operative Pain in Minimally Invasive Sacrocolpopexy

NCT05609682

Post Operative Pain

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be grouped into 2 groups of 25 patients each, the first group will receive 600 mg of gabapentin one hour before surgery and the second group will receive a placebo tablet. pain scores will be measured postoperatively

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

2 groups are included in the study

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

double-blinded study both participant and investigator are blind to the study drug

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

postoperative pain

Measuring postoperative pain using the visual analogue scale

Group Type NO_INTERVENTION

No interventions assigned to this group

total analgesic consumption

Recording the total amount of analgesia consumed by the patients

Group Type OTHER

Gabapentin

Intervention Type DRUG

single preoperative dose of 600 mg gabapentin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gabapentin

single preoperative dose of 600 mg gabapentin

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Gaptin 600 mg

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ASA physical status I or II
2. Aged from 18 to 65 years
3. Scheduled for anal surgeries at Minya University Hospital

Exclusion Criteria

1. Presence of contraindications to neuraxial anesthesia
2. Presence of history of central nervous system or mental disorders, epilepsy, chronic pain, or drug abuse.
3. The use of neuropathic analgesic or antiepileptic drugs

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No